These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2021756)

  • 1. Product licence applications.
    Wolff F
    BMJ; 1991 Mar; 302(6778):729. PubMed ID: 2021756
    [No Abstract]   [Full Text] [Related]  

  • 2. Framework and development of a comprehensive drug product coding system.
    DeVito CA; Aldridge GW; Wilson A; Vidis JS; Goldberg T; Dickson WM; Moore WE
    Contemp Pharm Pract; 1979; 2(2):62-5. PubMed ID: 10316818
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug scheduling--science and cultural perspective.
    Ray R; Dhawan A
    Addiction; 2010 Jul; 105(7):1151-3. PubMed ID: 20642501
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of United Kingdom product licence applications containing new active substances, 1987-9.
    Rawlins MD; Jefferys DB
    BMJ; 1991 Jan; 302(6770):223-5. PubMed ID: 1998766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Battle looms over regulatory classification of complex drugs.
    Hersher R
    Nat Med; 2012 Apr; 18(4):474-5. PubMed ID: 22481390
    [No Abstract]   [Full Text] [Related]  

  • 6. Old, new, and not new drugs.
    Knobloch CP
    J Am Vet Med Assoc; 1979 Oct; 175(7):698. PubMed ID: 528312
    [No Abstract]   [Full Text] [Related]  

  • 7. [Europeanisation of law. Demarcation issues in court].
    Schemmer F
    Pharm Unserer Zeit; 2011 Jul; 40(4):345-50. PubMed ID: 21698634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Microbiological and biological methods of the European Pharmacopoeia. Relevant for each medicinal product].
    Norwig J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1158-68. PubMed ID: 25200487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control listings ... narcotic and controlled drugs.
    Burnie CF
    Can Hosp; 1968 Mar; 45(3):39-45. PubMed ID: 5642767
    [No Abstract]   [Full Text] [Related]  

  • 10. A transition category of drugs: win-win-win-win?
    Marshall RP
    Am Pharm; 1992 Oct; NS32(10):64-7. PubMed ID: 1442533
    [No Abstract]   [Full Text] [Related]  

  • 11. Dentists and pharmacy law.
    Zacharczenko N
    N Y State Dent J; 1991 Nov; 57(9):75-6. PubMed ID: 1749570
    [No Abstract]   [Full Text] [Related]  

  • 12. [Doping in sports].
    Seĭfulla RD; Rozhkova EA; Rodchenkov GM; Appolonova SA; Kulikova EV
    Eksp Klin Farmakol; 2006; 69(6):68-72. PubMed ID: 17209468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Controlled Substances Act of 1970.
    Myers MA
    Alaska Med; 1971 Jul; 13(3):71-3. PubMed ID: 5562701
    [No Abstract]   [Full Text] [Related]  

  • 14. [What rules apply here and who is responsible? How drugs are distinguished from other health care products?].
    Stephan K
    Pharm Unserer Zeit; 2011 Jul; 40(4):300-4. PubMed ID: 21698627
    [No Abstract]   [Full Text] [Related]  

  • 15. ["Demarcation issues" - an unusual subject in Pharmazie in unserer Zeit? Not at all!].
    Knöss W; Dingermann T
    Pharm Unserer Zeit; 2011 Jul; 40(4):293. PubMed ID: 21695705
    [No Abstract]   [Full Text] [Related]  

  • 16. [A consideration from the scientific perspective. Health products: which is food, which is medicine?].
    Hahn A
    Pharm Unserer Zeit; 2011 Jul; 40(4):306-15. PubMed ID: 21698629
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs, codes, standards, and other incompatible things in the dark.
    Chute CG
    MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Royal Decree-Law 16/2012 on consumption of drugs excluded from public coverage in Navarre (Spain)].
    Aldaz P; Escalada D; Martínez-Monreal B; Azparren A; Ursúa ME
    Gac Sanit; 2015; 29(1):77-8. PubMed ID: 25200375
    [No Abstract]   [Full Text] [Related]  

  • 19. Suggestion for a study on the implications of various chemicals and non-disease specific drugs.
    Beaconsfield P; Rainsbury R; Huxley J; Peters R; Tréfouël J; Monod J; Paul R; Theorell H
    Experientia; 1971 Jun; 27(6):715-7. PubMed ID: 5559835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Procedure for inscription of drugs on the Social Security reimbursement list].
    Coudurier P
    Sem Hop; 1975 Nov; 51(45):Suppl 195-8. PubMed ID: 174206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.